Brief: Alligator Bioscience And Orion Corporation Initiate Second Program Of Immuno-Oncology Research Collaboration And License Agreement

Alligator Bioscience AB

02/01/2023 07:56

Jan 2 (Reuters) - Orion Corp  271560.KS :
    * ALLIGATOR BIOSCIENCE AND ORION CORPORATION ANNOUNCE THE
INITIATION OF THE SECOND PROGRAM OF THEIR IMMUNO-ONCOLOGY
RESEARCH COLLABORATION AND LICENSE AGREEMENT
    * EXPANSION TO RESEARCH COLLABORATION AND LICENSE AGREEMENT
WITH
ORION
    * INITIATION OF SECOND PROGRAM PROVIDES ALLIGATOR BIOSCIENCE
WITH
AN UPFRONT PAYMENT OF EUR 1.25 MILLION
    * WILL PROVIDE VALIDATED MONOSPECIFIC BINDERS FOR ONE
TARGET,
ORION WILL DO SAME FOR OTHER TARGET
    * EXTENDS COLLABORATION TO ADD DEVELOPMENT OF SECOND
BISPECIFIC
ANTIBODY

Source text for Eikon:  ID:nMFN2sP94x 
Further company coverage:  271560.KS 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))